Calithera Biosciences, Inc

CALA NASDAQ

PlanTradePlanMM

Wedge breakout + Consolidation Demand Zone confirmation Breakaway Gap OBV> OBV34 WR crossed -80 Entry 2 Stop 1.8 Target 3.6 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost. I created some tradingview...

c_myview

UPDATE

KM-

DOUBLE BOTTOM PATTERN, BULLISH DIVERGENCE. WE WILL SEE UPSIDE SOON. ALSO, THE GAP NEEDS TO BE FILLED (MINIMUM 100% PROFIT FROM CURRENT PRICE 2.01)

KM-

-

HorizontalPriceLevelsTrading

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm is functioned through the region of US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an...

manuchehr67

we have a shark pattern on the 2nd wave with a reversal point of $2.23 and on $2.1 C-1-2 could form the cypher pattern. so we have a reversal PRZ with two patterns and since the target of both two patterns is between $11 and $11.7 also we have a target PRZ. the candle of this week could be a beautiful reversal green hammer.

manuchehr67

Scenario 1 is more likely than Scenario 2

manuchehr67

after 5 or 6 could lift off and the lowest price could see is 2.5

HorizontalPriceLevelsTrading

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm is functioned through the region of US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an...

F_Investments

NASDAQ:CALA - Cup and handle - MACD sloping up - Buy price @ $ 5.01 - 1st target @ $ 5.73 - Stop loss @ $ 4.02

tickeron

This is a Bullish indicator signaling CALA's price could rise from here. Traders may explore going long the stock or buying call options. I identified 50 similar cases where CALA's MACD histogram became positive, and 44 of them led to successful outcomes. Odds of Success: 88%.

banjo_nz

Still indicates that the current trend will persist and may bounce on the trend-line I've drawn based on the weekly charts. The StochRSI is notably showing some weakness and including the MACD, ADX and DI. In the weekly chart it appears that there is a channel forming.

NAK1987

Analyst buy rating with good technical signs for long entry with tight stop . Entry 5.32 Stop 4.89 Take profit around 7.50 but adjust stop loss daily as this is forming a new trend still so where to take profit is a little harder to identify at this time .

shu88

According to the Stoch RSI we can see that this stock is currently oversold and it does look like $5.78 is the support. This could be an entry for a swing.

follow_the_money

After a recent selloff in mid June 2019, Stock price went from from $6.70 down to $3.44. Cala looks to have established a double bottom. New strong uptrend suggests it has potentially capitulated from the selloff making these levels very attractive for any investors who are sidelined and looking for a good technical/ fundamental trade in biotech. Cala looks to be...

trademics

WILL BE EYEING FOR A LONG THIS WEEK

djays1.618

Bottoming out-Vix dip-with a reversal=look for a CALA bounce 128%

Astatine

If the previous low holds, I fully expect a visit of the symmetric target for 3, sometime next year